↓ Skip to main content

JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer

Overview of attention for article published in Breast Cancer Research, May 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (76th percentile)
  • Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

patent
3 patents

Citations

dimensions_citation
96 Dimensions

Readers on

mendeley
56 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
JMJD6 is a driver of cellular proliferation and motility and a marker of poor prognosis in breast cancer
Published in
Breast Cancer Research, May 2012
DOI 10.1186/bcr3200
Pubmed ID
Authors

Yi Fang Lee, Lance David Miller, Xiu Bin Chan, Michael A Black, Brendan Pang, Chee Wee Ong, Manuel Salto-Tellez, Edison T Liu, Kartiki V Desai

Abstract

We developed an analytic strategy that correlates gene expression and clinical outcomes as a means to identify novel candidate oncogenes operative in breast cancer. This analysis, followed by functional characterization, resulted in the identification of Jumonji Domain Containing 6 (JMJD6) protein as a novel driver of oncogenic properties in breast cancer.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 4%
Hungary 1 2%
Malaysia 1 2%
Unknown 52 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 25%
Student > Master 9 16%
Researcher 8 14%
Student > Doctoral Student 4 7%
Student > Bachelor 4 7%
Other 8 14%
Unknown 9 16%
Readers by discipline Count As %
Agricultural and Biological Sciences 19 34%
Biochemistry, Genetics and Molecular Biology 10 18%
Medicine and Dentistry 7 13%
Chemistry 2 4%
Neuroscience 2 4%
Other 6 11%
Unknown 10 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 6. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 June 2022.
All research outputs
#5,446,629
of 25,373,627 outputs
Outputs from Breast Cancer Research
#643
of 2,052 outputs
Outputs of similar age
#35,820
of 177,809 outputs
Outputs of similar age from Breast Cancer Research
#7
of 37 outputs
Altmetric has tracked 25,373,627 research outputs across all sources so far. Compared to these this one has done well and is in the 75th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,052 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 12.2. This one has gotten more attention than average, scoring higher than 65% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 177,809 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 76% of its contemporaries.
We're also able to compare this research output to 37 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.